Brian Armstrong’s NewLimit Raises $435M for Human Trials

3 months ago 71
NewLimit raised $435M in Series C funding led by Founders Fund to advance its first age-reprogramming drug into human trials.
Read Entire Article
  1. Homepage
  2. BTCManager
  3. Brian Armstrong’s NewLimit Raises $435M for Human Trials

Related

Bitget offers 5% bounty for freezing funds stolen in $351.6M attack

Bitget offers 5% bounty for freezing funds stolen in $351.6M...

15 hours ago 26
Backpack CEO plans to bring 10,000 tokenized stocks to Solana

Backpack CEO plans to bring 10,000 tokenized stocks to Solan...

15 hours ago 27
Quant, Ethena and Bitway lead weekly crypto gains, can they hold?

Quant, Ethena and Bitway lead weekly crypto gains, can they ...

16 hours ago 27
Kalshi lost another appeals case. Can states regulate prediction markets as gambling?

Kalshi lost another appeals case. Can states regulate predic...

17 hours ago 25

Trending

Popular

Microsoft Copilot update sends shares up more than 4% on Friday

Microsoft Copilot update sends shares up more than 4% on Fri...

13 hours ago 241
Bitcoin Price Still 33% Below Its Peak High as Bulls Plot a Comeback

Bitcoin Price Still 33% Below Its Peak High as Bulls Plot a ...

13 hours ago 67
Bitget hacker withdraws $1.23M from Binance, funnels funds to attacker-controlled wallet

Bitget hacker withdraws $1.23M from Binance, funnels funds t...

21 hours ago 63
TypeSafe AI seeks $1B in funding as Jev model gains traction

TypeSafe AI seeks $1B in funding as Jev model gains traction...

12 hours ago 57
Google Vids offers 10 free AI video generations per month after April 2026 update

Google Vids offers 10 free AI video generations per month af...

12 hours ago 51
English (US) English (US) ·
About Us · Contact Us · Terms & Conditions · Press Release ·

© CoinDesk 2026. All rights are reserved